11th ANNUAL FORCE HEALTH PROTECTION CONFERENCE 9 -15 AUGUST 2008 9 - 10 August – Professional Skills Workshops 11-15 August – Core Conference

Albuquerque, NM

The 11th Annual Force Health Protection Conference, hosted by the U.S. Army Center for Health Promotion and Preventive Medicine, is held at the Albuquerque Convention Center, 9-15 August 2008. The theme is “prevention is the key.” CALL FOR PRESENTATIONS: Health Promotion for Readiness Track The Health Promotion for Readiness Track is seeking presentation abstracts in the areas of health promotion and preventive medicine for the 11th Annual Force Health Protection (FHP) Conference. The conference will feature presentations and posters judged as best among those submitted by scientists, engineers, technicians, physicians, and other health professionals from the U.S. Army; other Department of Defense and government organizations; allies and coalition partners; industry; and academia. The audience will include representatives from academia, industry, U.S. Government and allied nations. The Health Promotion for Readiness Track focuses on knowledge, skills, and tools that support force optimization, Army transformation, and healthy military communities in the areas of health promotion, preventive medicine, and public health. The track presents evidence-based, practical, and up-to-date health promotion and preventive medicine interventions and resources. The track also includes resources that address physical, mental, environmental, spiritual, health promotion and preventive medicine needs for military communities. This Health Promotion for Readiness Track will include: • Evidence-based science in support of current trends in health promotion • Pertinent information regarding Department of Defense (DoD) and public health policies • Strategies for implementing comprehensive installation community health promotion and well being programs • Methods for benchmarking, measuring, and reporting health promotion program effectiveness • Identification of health promotion objectives which impact strategic readiness and are aligned with Command goals and prioritization Interested conference presenters should submit an abstract according to the presentation guidelines listed below. The FHP web site can be accessed at: http://chppmwww.apgea.army.mil/fhp/.

1

PRESENTATION GUIDELINES DEADLINES: Registration is a pre-requisite before abstract submission. Abstracts submitted past the applicable submission will not be submitted for continuing education credits. Presentations not providing CEUs will be noted in the conference material for all applicable topics. Abstract submission on-line for all disciplines by: 31 March 2008 Author Notification of Acceptance: 22 April 2008 Final Presentations Due: 17 July 2008 DETAILS The Technical Program Committee composed of the Conference Director, Deputy Director, and technical experts, will select presentations on the basis of these abstracts. There are no limits regarding the number of abstracts any individual or organization may submit. For the abstract, the submitter must have obtained the required local disclosure authorization, security and OPSEC approvals that pertain to professional conferences open to academia, industry and allied nations. Please ensure that appropriate authorities (Public Affairs and Operations Security – for DoD personnel) at your organization review all presentations. A signed form will be required prior to presentation. All presentations must be releasable in the public domain. Documentation is to be provided to support the material in the presentation. Authors may submit presentations singly or in collaboration with colleagues in the Army, other government organizations, academia or industry. Material must represent original work and should be related to one of the technological areas noted above. FORMAT Only UNCLASSIFIED, Non-For Official Use Only abstracts that are 150 words or less will be accepted. Each abstract should be technically concise and indicate relevance to the military, in particular military medicine or occupational and environmental health. Results, conclusions and/or other significant items discussed in the papers should be included and the abstract should be complete in and of itself. Presentations MUST be cleared by your security personnel before submission. To receive credit, a presentation must be evidence based.

2

PRESENTATION INSTRUCTIONS 1. Read the Call for Presentations here: http://usachppm.apgea.army.mil/FHP/CallForPresentations.aspx 2. Follow the instructions at the bottom of that page to arrive at the abstract submission form. Note the deadline for submission. No abstracts can be accepted after March 31, 2008 electronically or by the FHP committee members. 3. Use the below template to help prepare your presentation information. It is suggested that you type out the below information here, save this file as a backup, and copy and paste these fields into the web form. (This file is an aid only and cannot be submitted.) 4. After you save your abstract, you will be asked to review and sign your CME/CEU form before your presentation will be considered. Note that you can no longer make changes to your submission at this point. If you discover any errors, send corrections to the FHP mailbox at: fhp@apgea.army.mil. Please include your name and the presentation title. 5. After submission, you will see a “Your Presentations” link in the left menu when you are logged in. Here, you can review and sign (if necessary) your presentations. Title: Additional Authors or Presenters: As
many as necessary. You must know the name and email address of each person.

Full Name
(ex: Mr. John Doe)

Email Address

Abstract: Up to 300 words. The presentation
abstract must be in a camera-ready format for placement in the Conference Brochure. The abstract should correspond to your objectives and include at least two (2) scientific references in the fields below.

References: Example Provide two (2) references from primary sources (research article published in a professional, peer-reviewed journal). Objectives: Example Up to 30 words each, at
least 2 required.

Introduction / Bio: Up to 150 words.
(Note: If you have presented at a previous FHP conference, your introduction and credentials will be pre-filled with your previous entries.)

Credentials: Up to 25 characters.

NOTE: In addition to the above fields, be prepared to indicate your intended audience, (i.e. physicians, IHs, ESOs, CHNs, OHNs, etc), the teaching methods you will use (i.e. lecture, panel discussion, etc), the duration of your presentation (30, 60, 90, or 120 minutes), list your education / degrees, and answer the following disclosure questions. 3

NOTE: Documentation of evidence to support integrity and scientific validity of clinical content. All recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients.

FACULTY DISCLOSURE INFORMATION 1. What is your role on this abstract and/or presentation? Please choose at least one. [Presenter and/or Author] 2. Within the last 12 months have you had a significant financial interest and/or other relationship with the manufacturer(s) of any of the product(s) or provider(s) of any of the services to be addressed in the educational activity? If YES, please list the manufacturer(s) or provider(s) and describe the nature of the relationship(s). 3. Within the last 12 months have you had a significant relationship(s) with the commercial supporter(s) of this activity? If YES, please list the relevant commercial supporter(s) and describe the nature of the Relationship(s). 4. When use of a non FDA-approved commercial product is discussed in a NMR Consulting, MedChi and USACHPPM-sponsored educational activity, NMR, MedChi and USACHPPM require that the speaker disclose the off-label or investigational use that will be discussed. I [will / will not] discuss off-label uses of products and/or devices. 5. Will the content that you provide to this PC MedChi and USACHPPM educational activity make any reference to experimental, FDA non-approved or investigational use(s) or pharmaceutical(s) and/or medical device(s) as described above? If YES, please list. RECOMMENDED FORMAT FOR REFERENCES Author(s). "Title of Article." Title of Journal, Volume, Issue (Year): pages. EXAMPLE Doe, John. "Low Level Exposures to Nerve Gas." Journal of Clinical Nerve Gas Research, 20(2), (2005): 165-174.

4

OBJECTIVES Objectives must be written for each abstract/topic. Objectives are to be written in measurable/observable terms (i.e. “understanding” can not be observed). a. Knowledge - Recognizes and recalls facts and specifics. Word's that reflect knowledge: define, record, name, memorize, list, relate, repeat, recall, and state. b. Comprehension - Interprets, translates, summarize or paraphrases information. Words that reflect comprehension: restate, tell, locate, discuss, review, identify, describe, report, express, recognize, and explain. c. Application - Uses information in a situation different from original learning context. Words that reflect application of knowledge: translate, employ, dramatize, interpret, use, practice, apply, demonstrate, illustrate, operate, schedule, and sketch d. Analysis - Separates whole into parts until relationship among elements is clear. Words that reflect analysis: classify, differentiate, experiment, distinguish, appraise, test, analyze, calculate, compare, contrast, criticize, diagram, question, relate, examine, translate, interpret, inventory, inspect, and debate e. Synthesis - Combines elements to form new entity from original ones. Words that reflect synthesis: synthesize, compose, plan, propose, design formulate, design, construct, create, set up, organize, manage, prepare, integrate, predict, summarize, assemble, collect, and arrange Below are examples of learning objectives 1. Describe the clinical presentation of ALL and prognostic factors. 2. Explain the differences in treatment and event-free survival between the adult and pediatric patient populations. 3. Evaluate current treatment strategies and assess goals for each. 4. Illustrate the role of asparagines depletion in combination chemotherapy regimens. 5. Compare and contrast available asparaginase formulations. All authors will be notified of the Technical Program Committee's action by 22 April 2008. Specific instructions for preparing the final presentations will be provided. Those authors who are selected must submit a completed presentation by 17 July 2008.

Questions may be directed to: fhp@apg.amedd.army.mil

THANK YOU. See you at the 11th Force Health Protection Conference in Albuquerque!

5